Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Convelo Therapeutics

Request full access

Innovative medicines unlocking the regenerative capacity of the central nervous system

Cleveland, United StatesFounded 2016Biotech & Life Sciences

About Convelo Therapeutics

Convelo Therapeutics is a biotechnology company focused on developing groundbreaking medicines that stimulate the regenerative capacity of the central nervous system (CNS). The company operates in the biotechnology and pharmaceutical markets, targeting neurological disorders that currently lack effective treatments. Convelo's innovative platform identifies novel candidate treatments capable of directly stimulating stem cells in the CNS to form new myelin, a critical component for nerve function. This approach aims to address unmet medical needs in conditions such as multiple sclerosis and other demyelinating diseases.

Convelo Therapeutics primarily serves patients suffering from neurological disorders, healthcare providers, and pharmaceutical companies looking for advanced treatment options. The business model revolves around research and development (R&D) of proprietary medicines, which are then brought to market through partnerships, licensing agreements, or direct commercialization. Revenue is generated through these partnerships, licensing deals, and eventual sales of approved therapies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
10
Open positions
None listed
Dealroom signal
79.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCOther financing Dec 2022 $11M $43M Undisclosed ↗
FundingOther financing Aug 2018 $7.8M — Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Convelo Therapeutics website traffic

Latest recorded traffic for Convelo Therapeutics is 600 monthly website visits, down 50% over the last three months. Convelo Therapeutics's team grew 0% over the past year.

Latest monthly visits600 3-month web change-50% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Convelo Therapeutics in the Cleveland ecosystem

Live from Dealroom

The Convelo Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors3 additional known investors

  • Case Western Reserve University
  • JobsOhio Ventures
  • JumpStart Ventures
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Convelo Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Convelo Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.